hrt and tirzepatide New research from a Mayo Clinic–led study suggests that postmenopausal women using menopause hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight obesity. In Hormone Therapy Boosts Weight-Loss Effects

However, researchers sometimes combine it with peptides that target entirely different pathways

The LDL figures it quotes are inconsistent between the summary and the body, so the direction of effect is more reliable than the exact percentage

Novo Nordisk (Denmark): Novo, as described above, dominates the GLP-1 market with products like Wegovy and Ozempic

MTHFR Testing Methylation refers to the biochemical pathway in which methyl groups (one carbon and three hydrogen atoms) are added to molecules

Isotretinoin can cause congenital disabilities, so patients who can become pregnant must follow strict safety rules

Some semaglutide and tirzepatide products are FDA-approved, but compounded versions are not